High mucosal healing rates in 5‐ASA‐treated ulcerative colitis patients: Results of a meta‐analysis of clinical trials

Background: Recently, mucosal healing (MH) is regarded as an important treatment goal in ulcerative colitis (UC). 5‐Aminosalicylates (5‐ASA) are the standard treatment in mild‐to‐moderate UC, but the effect on MH is less known. The aim of this study was to systematically review the medical literatur...

Full description

Bibliographic Details

Published in:	Inflammatory bowel diseases Vol. 18; no. 11; pp. 2190 - 2198
Main Authors:	Römkens, Tessa E.H., Kampschreur, Milou T., Drenth, Joost P.H., van Oijen, Martijn G.H., de Jong, Dirk J.
Format:	Journal Article
Language:	English
Published:	Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-11-2012 Oxford University Press
Subjects:	5‐ASA Clinical trials Clinical Trials as Topic Colitis, Ulcerative - drug therapy Drug therapy Humans Inflammatory bowel disease Intestinal Mucosa - drug effects Intestinal Mucosa - pathology Mesalamine - therapeutic use mucosal healing systematic review ulcerative colitis Wound Healing - drug effects
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!